Vanilloid receptor ligands and their use in treatments
    81.
    发明授权
    Vanilloid receptor ligands and their use in treatments 失效
    香草素受体配体及其在治疗中的应用

    公开(公告)号:US07582761B2

    公开(公告)日:2009-09-01

    申请号:US10688246

    申请日:2003-10-16

    Abstract: Therapeutic benzimidazoles having the general structure: and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

    Abstract translation: 具有一般结构的治疗性苯并咪唑和含有它们的组合物,用于治疗急性,炎性和神经性疼痛,牙痛,一般头痛,偏头痛,丛集性头痛,混合血管和非血管综合征,紧张性头痛,一般炎症,关节炎 ,风湿性疾病,骨关节炎,炎症性肠病,炎症性眼病,炎性或不稳定性膀胱疾病,牛皮癣,皮肤炎症成分炎症,慢性炎性病症,炎症性疼痛及相关的痛觉过敏和异常性疼痛,神经性疼痛和相关的痛觉过敏和异常性疼痛,糖尿病性神经病变 疼痛,咳嗽,交感神经保持疼痛,交感综合征,哮喘,上皮组织损伤或功能障碍,单纯疱疹,呼吸道内脏运动紊乱,泌尿生殖道,胃肠道或血管区,伤口,烧伤,过敏性皮肤反应,瘙痒,白癜风, 胃肠疾病,胃溃疡,十二指肠溃疡,腹泻,坏死因子诱导的胃损伤,毛发生长,血管舒缩或过敏性鼻炎,支气管疾病或膀胱疾病。

    Substituted heterocyclic compounds and methods of use
    82.
    发明授权
    Substituted heterocyclic compounds and methods of use 有权
    取代的杂环化合物及其使用方法

    公开(公告)号:US07582631B2

    公开(公告)日:2009-09-01

    申请号:US11034042

    申请日:2005-01-11

    Abstract: The present invention relates to therapeutic diazobicyclo pyridines and their use in the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis or osteoarthritis, organ transplant, acute transplant or heterograft and homograft rejection, ischemic and reperfusion injury, transplantation tolerance induction, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, lupus, graft vs. host diseases, T -cell mediated hypersensitivity diseases, contact hypersensitivity, delayed-type hypersensitivity, gluten-sensitive enteropathy, Type 1 diabetes, psoriasis, contact dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Graves' Disease, Addison's disease, autoimmune polyglandular disease, autoimmune alopecia, pernicious anemia, vitiligo, autoimmune hypopituatarism, Guillain-Barre syndrome, autoimmune diseases, glomerulonephritis, serum sickness, uticaria, respiratory allergies, asthma, hayfever, allergic rhinitis, skin allergies, scleracielma, mycosis fungoides, acute inflammatory responses, acute respiratory distress syndrome, dermatomyositis, alopecia areata, chronic actinic dermatitis, eczema, Behcet's disease, Pustulosis palmoplanteris, Pyoderma gangrenum, Sezary's syndrome, atopic dermatitis, systemic schlerosis, morphea, Type II diabetes and cancers where PKC theta or other PKC-family kinases are activated, overexpressed or facilitate tumor growth or survival of tumor cells, T cell leukemia, thymoma, T and B cell lymphoma, colon carcinoma, breast carcinoma and lung carcinoma or provides resistance to chemotherapeutic drugs.

    Abstract translation: 本发明涉及治疗性重氮二环吡啶及其在治疗关节炎,类风湿性关节炎,银屑病关节炎或骨关节炎,器官移植,急性移植或异种移植和同种异体移植排斥,缺血和再灌注损伤,移植耐受诱导,多发性硬化,炎性肠中的用途 疾病,溃疡性结肠炎,克罗恩病,狼疮,移植物抗宿主病,T细胞介导的超敏反应性疾病,接触性超敏反应,延迟型超敏反应,麸质敏感性肠病,1型糖尿病,牛皮癣,接触性皮炎,桥本氏甲状腺炎,干燥综合征 ,自身免疫性甲状腺功能亢进症,格雷夫斯病,艾迪生病,自身免疫性多腺病,自身免疫性脱发,恶性贫血,白癜风,自身免疫性低分化症,吉兰巴利综合征,自身免疫性疾病,肾小球肾炎,血清病,荨麻疹,呼吸道过敏,哮喘,过敏性鼻炎,过敏性鼻炎 ,皮肤过敏 es,scleracielma,蕈样真菌病,急性炎症反应,急性呼吸窘迫综合征,皮肌炎,斑秃,慢性光化性皮炎,湿疹,Behcet氏病,脓疱疮,新生皮炎,Sezary综合征,特应性皮炎,全身性硬化症,morphea,II型糖尿病 和PKCθ或其他PKC家族激酶被激活,过度表达或促进肿瘤细胞,T细胞白血病,胸腺瘤,T细胞和B细胞淋巴瘤,结肠癌,乳腺癌和肺癌的肿瘤生长或存活的癌症,或提供对化学治疗的抗性 药物

Patent Agency Ranking